Question: iPSC reprogramming efficiency optimization protocols
[coverage] Do Trevisan et al. 2017's episomal and retroviral arms state a replating or split fraction anywhere in the paper (results, supplementary methods), the way its Sendai arm does, and does any paper beyond this ten-paper seed list correct its reported efficiency for replating the way Warren 2010 does?
Needs new evidence20 verified (technical)
1/3 publication-ready
Findings metrics
—
total
—
verified
—
pending
—
rejected